Natera Announces Completion of Signatera™ Analysis from the CALGB (Alliance)/SWOG 80702 Randomized, Phase III Clinical Trial in Colorectal Cancer
Go back to Natera Announces Completion of Signatera™ Analysis from the CALGB (Alliance)/SWOG 80702 Randomized, Phase III Clinical Trial in Colorectal Cancer| (NASDAQ: NTRA) | Delayed: 361.73 -4.58 (1.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $366.31 | 52 Week High | $13.80 | |||
| Open | $365.78 | 52 Week Low | $6.52 | |||
| Day High | $367.00 | P/E | N/A | |||
| Day Low | $358.90 | EPS | $0.00 | |||
| Volume | 666,396 | |||||
